ETF · holdings as filed 2026-04-30

What's inside LABU?

Direxion Daily S&P Biotech Bull 3X Shares
Holdings
154
positions in the fund
Top 10
30%
of fund assets
Expense ratio
0.93%
net, per year
Fund size
$519M
total net assets

Top 20 holdings

Sectors
Top holdings — Health Care
Your 10 largest positions in this sector
1
R
RVMDREVOLUTION MEDICINES INC
1.27%
2
T
TVTXTRAVERE THERAPEUTICS INC
1.25%
3
A
ARWRARROWHEAD PHARMACEUTICALS IN
1.11%
4
T
TWSTTWIST BIOSCIENCE CORP
1.10%
5
S
SMMTSUMMIT THERAPEUTICS INC
1.09%
6
A
ALKSALKERMES PLC
1.07%
7
T
TGTXTG THERAPEUTICS INC
1.06%
8
M
MDGLMADRIGAL PHARMACEUTICALS INC
1.06%
9
B
BEAMBEAM THERAPEUTICS INC
1.02%
10
A
APGEAPOGEE THERAPEUTICS INC
0.98%
Geography
Top holdings — United States
Your 10 largest positions in this country
1
R
RVMDREVOLUTION MEDICINES INC
1.27%
2
T
TVTXTRAVERE THERAPEUTICS INC
1.25%
3
A
ARWRARROWHEAD PHARMACEUTICALS IN
1.11%
4
T
TWSTTWIST BIOSCIENCE CORP
1.10%
5
S
SMMTSUMMIT THERAPEUTICS INC
1.09%
6
T
TGTXTG THERAPEUTICS INC
1.06%
7
M
MDGLMADRIGAL PHARMACEUTICALS INC
1.06%
8
B
BEAMBEAM THERAPEUTICS INC
1.02%
9
A
APGEAPOGEE THERAPEUTICS INC
0.98%
10
S
SRRKSCHOLAR ROCK HOLDING CORP
0.95%
Geography reflects each issuer's registered business address per SEC EDGAR filings where available, falling back to the exchange or listing where no SEC filing exists — not necessarily where a company's stock is primarily listed (e.g. TSMC is classified as Taiwan even though its ADR trades on the NYSE).
Hold LABU alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings (as of 2026-04-30); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.